Mutations in HNF1A result in marked alterations of plasma glycan profile

Diabetes

Volumn 62, Issue 4, 2013, Pages 1329-1337

  Thanabalasingham, Gaya ^a,b   Huffman, Jennifer E ^c   Kattla, Jayesh J ^d   Novokmet, Mislav ^e   Rudan, Igor ^f,g   Gloyn, Anna L ^a,b   Hayward, Caroline ^c   Adamczyk, Barbara ^d   Reynolds, Rebecca M ^f   Muzinic, Ana ^e   Hassanali, Neelam ^a   Pucic, Maja ^e   Bennett, Amanda J ^a   Essafi, Abdelkader ^c   Polasek, Ozren ^g   Mughal, Saima A ^a,b   Redzic, Irma ^h   Primorac, Dragan ^g,i   Zgaga, Lina ^f   Kolcic, Ivana ^g   Hansen, Torben ^j,k,l   Gasperikova, Daniela ^m   Tjora, Erling ^n,o   Strachan, Mark W J ^p   Nielsen, Trine ^j   Stanik, Juraj ^m,q   Klimes, Iwar ^m   Pedersen, Oluf B ^j,r,s   Njølstad, Pål R ^n,o   Wild, Sarah H ^f   Gyllensten, Ulf ^t   Gornik, Olga ^h   Wilson, James F ^f   Hastie, Nicholas D ^c   Campbell, Harry ^f   McCarthy, Mark I ^a,b,u   Rudd, Pauline M ^d   Owen, Katharine R ^a,b   Lauc, Gordan ^e,h   Wright, Alan F ^c   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING   (Ireland)

^e GENOS GLYCOSCIENCE RESEARCH LABORATORY   (Croatia)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

^g UNIVERSITY OF SPLIT   (Croatia)

^h UNIVERSITY OF ZAGREB   (Croatia)

ⁱ JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^j Capital Region   (Denmark)

^k UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^l STENO DIABETES CENTER   (Denmark)

^m INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

ⁿ UNIVERSITY OF BERGEN   (Norway)

^o HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^p WESTERN GENERAL HOSPITAL   (United Kingdom)

^q Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^r AARHUS UNIVERSITY   (Denmark)

^s HAGEDORN RESEARCH INSTITUTE   (Denmark)

^t UPPSALA UNIVERSITY   (Sweden)

^u UNIVERSITY OF OXFORD   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLYCAN; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; PLASMA PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DG9 GLYCAN INDEX; DIAGNOSTIC VALUE; FEMALE; FUCOSYLATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LOSS OF FUNCTION MUTATION; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION REGULATION; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYSACCHARIDES; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84875424999     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0880     Document Type: Article

References (40)

1. Lauc G, Essafi A, Huffman JE, et al. Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1a as a master regulator of plasma protein fucosylation. PLoS Genet 2010;6:e1001256
2. Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim Biophys Acta 1999;1473:4-8
3. Cummings RD. The repertoire of glycan determinants in the human glycome. Mol Biosyst 2009;5:1087-1104
4. Trinchera M, Malagolini N, Chiricolo M, et al. The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach. Int J Biochem Cell Biol 2011;43:130-139
5. Thanabalasingham G, Owen KR. Diagnosis and management of maturity onset diabetes of the young (MODY). BMJ 2011;343:d6044
6. Ellard S, Bellanné-Chantelot C, Hattersley AT; European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008;51:546-553
7. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 2010;53:2504-2508
8. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003;362:1275-1281
9. Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT. A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 2009;26: 437-441
10. Gornik O, Wagner J, Pucic M, Knezevic A, Redzic I, Lauc G. Stability of N-glycan profiles in human plasma. Glycobiology 2009;19:1547-1553
11. Knezevic A, Polasek O, Gornik O, et al. Variability, heritability and environmental determinants of human plasma N-glycome. J Proteome Res 2009;8:694-701
12. Royle L, Campbell MP, Radcliffe CM, et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem 2008;376:1-12
13. Thanabalasingham G, Pal A, Selwood MP, et al. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young. Diabetes Care 2012;35:1206-1212
14. Harries LW, Ellard S, Stride A, Morgan NG, Hattersley AT. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Hum Mol Genet 2006;15:2216-2224
15. Bellanné-Chantelot C, Carette C, Riveline JP, et al. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes 2008;57: 503-508
16. González-Pérez A, López-Bigas N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet 2011;88:440-449
17. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073-1081
18. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-249
19. Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res 2011;39:e118
20. Harvey DJ, Merry AH, Royle L, Campbell MP, Dwek RA, Rudd PM. Proposal for a standard system for drawing structural diagrams of N-and O-linked carbohydrates and related compounds. Proteomics 2009;9:3796-3801
21. Owen KR, Thanabalasingham G, James TJ, et al. Assessment of highsensitivity C-reactive protein levels as diagnostic discriminator of maturityonset diabetes of the young due to HNF1A mutations. Diabetes Care 2010; 33:1919-1924
22. Thanabalasingham G, Shah N, Vaxillaire M, et al. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia 2011;54:2801-2810
23. Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Hum Mutat 2006;27:854-869
24. 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 2010;467:1061-1073
25. National Heart, Lung, and Blood Institute. NHLBI Exome Sequencing Project (ESP. Exome Variant Server [Internet]. Seattle, WA, NESPE. Available from http://evs.gs.washington.edu/EVS/. Accessed June 2012
26. Bingham C, Ellard S, Nicholls AJ, et al. The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria. Diabetes 2001;50:2047-2052
27. Stride A, Pearson ER, Brown A, Gooding K, Castleden HA, Hattersley AT. Serum amino acids in patients with mutations in the hepatocyte nuclear factor-1 alpha gene. Diabet Med 2004;21:928-930
28. Cervin C, Axler O, Holmkvist J, et al. An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA. J Intern Med 2010;267:316-321
29. Pal A, Farmer AJ, Dudley C, et al. Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes. Diabetes Care 2010;33:252-257
30. Richter S, Shih DQ, Pearson ER, et al. Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. Diabetes 2003;52:2989-2995
31. Skupien J, Gorczynska-Kosiorz S, Klupa T, et al. Clinical application of 1,5-anhydroglucitol measurements in patients with hepatocyte nuclear factor-1alpha maturity-onset diabetes of the young. Diabetes Care 2008;31:1496-1501
32. Skupien J, Kepka G, Gorczynska-Kosiorz S, et al. Evaluation of Apolipoprotein M Serum Concentration as a Biomarker of HNF-1alpha MODY. Rev Diabet Stud 2007;4:231-235
33. McDonald TJ, Shields BM, Lawry J, et al. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 2011; 34:1860-1862
34. Gornik O, Royle L, Harvey DJ, et al. Changes of serum glycans during sepsis and acute pancreatitis. Glycobiology 2007;17:1321-1332
35. Besser RE, Shepherd MH, McDonald TJ, et al. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-alpha/hepatocyte nuclear factor 4-alpha maturity-onset diabetes of the young from long-duration type 1 diabetes. Diabetes Care 2011;34:286-291
36. Knezevic A, Gornik O, Polasek O, et al. Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology 2010;20:959-969
37. McDonald TJ, Colclough K, Brown R, et al. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes. Diabet Med 2011;28:1028-1033
38. Copas JB. Overestimation of the receiver operating characteristic curve for logistic regression. Biometrika 2002;89:315-331
39. Vaxillaire M, Abderrahmani A, Boutin P, et al. Anatomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J Biol Chem 1999; 274:35639-35646
40. Yoshiuchi I, Yamagata K, Yang Q, et al. Three new mutations in the hepatocyte nuclear factor-1alpha gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization. Diabetologia 1999;42:621-626